AIDS-related Funding Opportunity Announcements (FOAs)

NIMH Notices of Funding Opportunities

Request for Applications (RFA)

RFA-MH-24-100: RFA-MH-24-100: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed) 

RFA-MH-24-235: Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed) 

RFA-MH-24-330: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional) 

RFA-MH-24-331: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional) 

RFA-MH-24-332: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)  

Notice of Special Interest (NOSI)

NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment and Cure 

NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others 

NOT-MH-23-100: Notice of Data Sharing Policy for the National Institute of Mental Health 

NOT-MH-23-200: Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations 

NOT-MH-23-250: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults 

NOT-MH-23-265: Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment 

NOT-MH-23-270: Intersectional Stigma and Discrimination (ISD), or Other Social Determinants of Health (SSDOH) in HIV Prevention and Treatment 

NOT-MH-23-275: Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets 

NOT-MH-23-350: Notice of Special Interest (NOSI): Advancing Data Science Research in HIV: Responding to a Dynamic, Complex, and Evolving HIV Epidemic with Artificial Intelligence/Machine Learning 

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-20-307: Developmental AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 

PAR-20-308: NIMH AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 

PAR-21-228: NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) 

PAR-23-060: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional) 

PAR-23-061: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Option) 

PAR-23-062: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Option) 

Co-Sponsored Funding Opportunities

Notice of Special Interest (NOSI)

NOT-AI-21-011: Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research 

NOT-AI-21-054: Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV 

NOT-AI-21-057: Notice of Special Interest (NOSI): HIV/AIDS in the Era of COVID-19: When Pandemics Collide 

NOT-AI-22-042: Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) 

NOT-AI-22-072: Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation 

NOT-CA-22-037: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research 

NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings 

NOT-OD-21-100: Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health 

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) 

PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults 

PAR-22-151: Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) 

PAR-22-152: Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) 

PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) 

PAR-22-252: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) 

PAR-23-245: Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)